Is an Oral Glucose Tolerance Test Still Valid for Diagnosing Diabetes Mellitus?

다국어 초록 (Multilingual Abstract)

Background: We evaluated the diagnostic rate of diabetes using fasting plasma glucose (FPG), 2-hour plasma glucose (2h PG) after 75 g oral glucose tolerance test (OGTT), and glycosylated hemoglobin (HbA1c) levels, and we elucidated the pathophysiologic characteristics and risk factors that give rise to diabetes in patients with prediabetes.
Methods: The data of 236 patients who had the OGTT at Konkuk University Hospital were analyzed. Fasting, 30, and 120 minutes blood glucose levels and insulin levels were measured. The diagnostic rate of diabetes was assessed using FPG, 2h PG, and HbA1c levels. The clinical data and insulin resistance and secretion evaluations were compared using indexes according to the fasting glucose level.
Results: Among 236 subjects, 97 (41.1%) were diabetics and 102 (43.2%) were prediabetics. The rate of diabetes diagnosis by one of the individual criteria was 56.7%, 53.6%, and 84.5% for FPG, HbA1c, and 2h PG, respectively. When two criteria were used to diagnose diabetes, 72.2% of the diabetic patients were identified by FPG and HbA1c, while 100% were identified by FPG and 2h PG, and 91.7% were identified by 2h PG and HbA1c. The HbA1c cut-off value for 2h PG ≥200 mg/dL was 6.1%, and the FPG cut-off value was 115 mg/dL. In impaired fasting glucose subjects, the HbA1c level, Matsuda index, and insulinogenic index were associated with risk of occurrence of overt diabetes (P<0.01).
Conclusion: This study suggests that performing additional OGTT for patients with FPG ≥110 mg/dL or HbA1c ≥6.1% is helpful to reclassify their glucose tolerance status and evaluate their potential for progressing to overt diabetes.

참고문헌 (Reference)

1 Gutt M, "Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures" 47 : 177-184, 2000

2 World Health Organization, "Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation" WHO 2011

3 Nolan CJ, "Type 2 diabetes across generations: from pathophysiology to prevention and management" 378 : 169-181, 2011

4 Chen L, "The worldwide epidemiology of type 2 diabetes mellitus: present and future perspectives" 8 : 228-236, 2012

5 Bartoli E, "The oral glucose tolerance test (OGTT) revisited" 22 : 8-12, 2011

6 English E, "The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review" 58 : 1409-1421, 2015

7 Oh JY, "The diagnosis of diabetes mellitus in Korea: a pooled analysis of four community-based cohort studies" 24 : 217-218, 2007

8 Herman WH, "The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance" 142 : 323-332, 2005

9 DeFronzo RA, "Reduced time points to calculate the composite index" 33 : e93-, 2010

10 전자영, "Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c" 대한당뇨병학회 37 (37): 349-357, 2013

11 Utzschneider KM, "Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels" 32 : 335-341, 2009

12 Lee H, "Optimal hemoglobin A1C cutoff value for diagnosing type 2 diabetes mellitus in Korean adults" 99 : 231-236, 2013

13 Matsuda M, "Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp" 22 : 1462-1470, 1999

14 Matthews DR, "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man" 28 : 412-419, 1985

15 김정민, "Glycated Hemoglobin Value for Fasting Plasma Glucose of 126 mg/dL in Korean: The 2011 Korea National Health and Nutrition Examination Survey" 대한당뇨병학회 38 (38): 480-483, 2014

16 Wild S, "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030" 27 : 1047-1053, 2004

17 Guariguata L, "Global estimates of diabetes prevalence for 2013 and projections for 2035" 103 : 137-149, 2014

18 Genuth S, "Follow-up report on the diagnosis of diabetes mellitus" 36 : 3160-3167, 2003

19 Yoon KH, "Epidemic obesity and type 2 diabetes in Asia" 368 : 1681-1688, 2006

20 Gaede P, "Effect of a multifactorial intervention on mortality in type 2 diabetes" 358 : 580-591, 2008

21 박이병, "Diabetes Epidemics in Korea: Reappraise Nationwide Survey of Diabetes “Diabetes in Korea 2007”" 대한당뇨병학회 37 (37): 233-239, 2013

22 Hong JW, "Association between the presence of iron deficiency anemia and hemoglobin A1c in Korean adults: the 2011-2012 Korea National Health and Nutrition Examination Survey" 94 : e825-, 2015

23 Lu ZX, "A1C for screening and diagnosis of type 2 diabetes in routine clinical practice" 33 : 817-819, 2010

24 Kramer CK, "A1C and diabetes diagnosis: the Rancho Bernardo Study" 33 : 101-103, 2010

25 Oh JY, "A report on the diagnosis of intermediate hyperglycemia in Korea: a pooled analysis of four community-based cohort studies" 80 : 463-468, 2008

26 Holman RR, "10-year follow-up of intensive glucose control in type 2 diabetes" 359 : 1577-1589, 2008

27 American Diabetes Association, "(2) Classification and diagnosis of diabetes" 38 (38): S8-S16, 2015